Genedata and Roche extend biomarker discovery collaboration
Genedata, a provider of in-silico solutions for pharmaceutical R&D and related life sciences, has extended its three-year license agreement with Roche for the Refiner MS module of the Genedata Expressionist biomarker discovery system.
Refiner MS solves key requirements of large-scale proteomics and metabolomics facilities that need to efficiently process, analyse and store mass spectrometry (MS) data. As an integral part of the Expressionist biomarker discovery system, Refiner MS performs automated pre-processing of MS raw data and delivers quantified peak data ready for analysis or for storage in its relational database. Refiner MS is a workflow-based client-server application designed to process thousands of samples simultaneously.
'Efficient processing of raw chromatograms, accurate peak detection prior to peak identification, customisable workflows and large-scale sample processing are essential components that Refiner MS adds to the Roche biomarker discovery process,' said Dr Hanno Langen, global head of protein biomarker technologies at the Roche Molecular Medicine Laboratories. 'With Refiner MS we are now able to standardise clinical proteomics applications and ensure the quality of results in this emerging field.'